Christopher R. Fenimore, CFO of Regeneron Pharmaceuticals REGN, has filed 0 purchases and 21 sales on the open market. The latest trade was on 25/12/08.

CF

CF

Christopher R. Fenimore

EVP Finance CFO

Company

Regeneron Pharmaceuticals REGN

First filing

23/02/07

Trades

52 trades

Buys / sales

0 / 21

12-month net buying

No record

Last trade

25/12/08

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Regeneron PharmaceuticalsREGN	Open-market sale	24/08/28	24/08/29	5,680 sh10 trades	$1,205.33avg.	$6,846,262.22	−99.6%
Regeneron PharmaceuticalsREGN	Open-market sale	24/02/09	24/02/12	4,919 sh6 trades	$953.31avg.	$4,689,319.75	−25.5%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/12/27	23/12/29	2,448 sh	$856.71	$2,097,226.08	−14.6%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/12/21–23/12/22	23/12/26	1,930 sh3 trades	$844.30avg.	$1,629,501.9	−10.3%
Regeneron PharmaceuticalsREGN	Open-market sale10b5-1 plan	23/03/23	23/03/27	2,192 sh	$806.47	$1,767,782.24	−10.6%